Mary Newman, SVP, Regulatory Affairs at Audentes Therapeutics, Inc. (BOLD), sold 20,000 shares at $27.31 ($537K) on 2017-11-16, disclosed to the SEC on 2017-11-17.
Open-market sale of $537k BOLD by SVP, Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.49 | 5,740 | $152K | 28.3% |
| 2 | $26.49 | 5,740 | $152K | 28.3% |
| 3 | $27.31 | 4,260 | $116K | 21.7% |
| 4 | $27.31 | 4,260 | $116K | 21.7% |
| Total | $26.84 avg | 20,000 | $537K | 100% |
| Filing → |
| BOLD | SELL | 2017-08-25 | $200K | — | Filing → |